These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23243695)

  • 1. ACE inhibitors may lower pneumonia risk.
    Harv Health Lett; 2012 Oct; 37(12):8. PubMed ID: 23243695
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumonia and ACE inhibitors--and cough.
    Barnes RA
    BMJ; 2012 Jul; 345():e4566. PubMed ID: 22786936
    [No Abstract]   [Full Text] [Related]  

  • 3. Popular cardiac drug may prevent pneumonia.
    Harv Mens Health Watch; 2012 Oct; 17(3):8. PubMed ID: 23175869
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors and bacterial pneumonia in patients with Parkinson disease.
    Wang HC; Lin CC; Lau CI; Chang A; Kao CH
    Mov Disord; 2015 Apr; 30(4):593-6. PubMed ID: 25641619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of dementia by ACE inhibitors and angiotensin receptor blockers - potential but not proven.
    Todd S; McGuinness B; Passmore AP
    Int J Clin Pract; 2010 Nov; 64(12):1595-8. PubMed ID: 20946266
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors, angiotensin-II receptor antagonists, and pneumonia in elderly hypertensive patients with stroke.
    Arai T; Yasuda Y; Takaya T; Toshima S; Kashiki Y; Shibayama M; Yoshimi N; Fujiwara H
    Chest; 2001 Feb; 119(2):660-1. PubMed ID: 11171758
    [No Abstract]   [Full Text] [Related]  

  • 7. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study.
    Etminan M; Zhang B; Fitzgerald M; Brophy JM
    Pharmacotherapy; 2006 Apr; 26(4):479-82. PubMed ID: 16553505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on risk of atrial fibrillation before coronary artery bypass grafting.
    Johnston K; Stephens S
    Ann Pharmacother; 2012 Sep; 46(9):1239-44. PubMed ID: 22947592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review.
    Ferrari R; Boersma E
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):705-17. PubMed ID: 23750680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy.
    Pathak JV; Dass EE
    Indian J Pharmacol; 2015; 47(2):148-52. PubMed ID: 25878372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials.
    Tocci G; Paneni F; Palano F; Sciarretta S; Ferrucci A; Kurtz T; Mancia G; Volpe M
    Am J Hypertens; 2011 May; 24(5):582-90. PubMed ID: 21331058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure.
    Savarese G; Costanzo P; Cleland JG; Vassallo E; Ruggiero D; Rosano G; Perrone-Filardi P
    J Am Coll Cardiol; 2013 Jan; 61(2):131-42. PubMed ID: 23219304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-hypertensive treatment in metabolic syndrome--focus on ARB or ACE inhibitor].
    Yano Y; Kario K
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():576-81. PubMed ID: 21766663
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension: are they equivalent?
    Kaplan NM
    J Am Soc Hypertens; 2015 Aug; 9(8):582-3. PubMed ID: 26319536
    [No Abstract]   [Full Text] [Related]  

  • 15. The Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Postangioplasty Restenosis.
    Liu Y; Carrey Z; Aronow WS; Alaie D; Petrillo RL; Frishman WH
    Am J Ther; 2015; 22(4):e107-14. PubMed ID: 23782765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers.
    Tazkarji B; Ganeshamoorthy A; Auten B
    Am Fam Physician; 2015 Feb; 91(3):193-4. PubMed ID: 25822274
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
    Savarese G; Edner M; Dahlström U; Perrone-Filardi P; Hage C; Cosentino F; Lund LH
    Int J Cardiol; 2015 Nov; 199():415-23. PubMed ID: 26247798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not just numbers, but years of science: putting the ACE inhibitor-ARB meta-analyses into context.
    Ferrari R; Rosano GM
    Int J Cardiol; 2013 Jun; 166(2):286-8. PubMed ID: 23452882
    [No Abstract]   [Full Text] [Related]  

  • 19. ACE inhibitors and reduction of the risk of pneumonia in elderly people.
    Arai T; Yasuda Y; Takaya T; Toshima S; Kashiki Y; Yoshimi N; Shibayama M; Fujiwara H
    Am J Hypertens; 2000 Sep; 13(9):1050-1. PubMed ID: 10981561
    [No Abstract]   [Full Text] [Related]  

  • 20. In patients with chronic diabetic nephropathy, do angiotensin-converting enzyme inhibitors (ACEI) have greater renal protective effect as compared to angiotensin receptor blockers (ARB)?
    Tucker S; Chen Y; Abell R
    J Okla State Med Assoc; 2013 Jul; 106(7):294-5. PubMed ID: 24032256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.